SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Marina Biotech, Inc. (Formerly Known as MDRNA, Inc.) Completes Dosing of Second Cohort in the Phase 1b START-FAP Clinical Trial of CEQ508